Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10558)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2019 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World J Gastroenterol 2019; 25(32): 4614-4628 [PMID: PMC6718039 DOI: 10.3748/wjg.v25.i32.4614] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i32/4614.htm |
| Number | Citing Articles |
| 1 |
Maryam Haghshomar, Darren Rodrigues, Aparna Kalyan, Yury Velichko, Amir Borhani. Leveraging radiomics and AI for precision diagnosis and prognostication of liver malignancies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1362737
|
| 2 |
Bogdan Gherman, Corina Radu, Andrei Caprariu, Nadim Al Hajjar, Calin Vaida, Andra Ciocan, Paul Tucan, Emil Mois, Doina Pisla. Advances in Service and Industrial Robotics. Mechanisms and Machine Science 2023; 135: 245 doi: 10.1007/978-3-031-32606-6_29
|
| 3 |
Vincent Chin-Hung Chen, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, Roger S. McIntyre. Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. International Journal of Molecular Sciences 2023; 24(16): 12630 doi: 10.3390/ijms241612630
|
| 4 |
Yipeng Ma, Jiayu Ou, Tong Lin, Lei Chen, Junhui Chen, Mingjun Wang. Next Generation Sequencing‐Based Identification of T‐Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma. Hepatology Communications 2021; 5(6): 1106 doi: 10.1002/hep4.1697
|
| 5 |
Kali Zhou, Neil Mehta. Downstaging to Liver Transplant. Clinics in Liver Disease 2020; 24(4): 665 doi: 10.1016/j.cld.2020.07.005
|
| 6 |
Zhitao Chen, Tielong Wang, Chuanbao Chen, Xitao Hong, Jia Yu, Yihao Ma, Yiwen Guo, Changjun Huang, Xiaoshun He, Weiqiang Ju, Maogen Chen, Irena Ilic. Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/7776389
|
| 7 |
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of Hepatocellular Carcinoma 2023; : 2021 doi: 10.2147/JHC.S407680
|
| 8 |
Charlotte Ebeling Barbier, Femke Heindryckx, Hans Lennernäs. Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(23): 13051 doi: 10.3390/ijms222313051
|
| 9 |
Alexander E. Hare, Mina S. Makary. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 307 doi: 10.1007/16833_2022_42
|
| 10 |
Bart Vanderborght, Sander Lefere, Hans Van Vlierberghe, Lindsey Devisscher. The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. Cells 2020; 9(11): 2382 doi: 10.3390/cells9112382
|
| 11 |
Tao Ouyang, Xuefeng Kan, Chuansheng Zheng. Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.898964
|
| 12 |
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
|
| 13 |
Katia Pinheiro de Souza, Antonio Rahal, Erivelto Martinho Volpi, Priscila Mina Falsarella, Jairo Tabacow Hidal, Danielle Macellaro Andreoni, Miguel Jose Francisco-Neto, Marcos Roberto Gomes de Queiroz, Rodrigo Gobbo Garcia. Hydrodissection and programmed stop sedation in 100 % of benign thyroid nodules treated with radiofrequency ablation. European Journal of Radiology 2020; 133: 109354 doi: 10.1016/j.ejrad.2020.109354
|
| 14 |
Roberto Iezzi, Alessandro Posa, Cosimo Tommaso Caputo, Davide De Leoni, Fabio Sbaraglia, Marco Rossi, Giampaolo Tortora, Luca Tagliaferri, Vincenzo Valentini, Cesare Colosimo. Safety and Feasibility of Analgosedation for Electrochemotherapy of Liver Lesions. Life 2023; 13(3): 631 doi: 10.3390/life13030631
|
| 15 |
Ning Qi Pang, Paolo Magistri, Stefano Di Sandro, Fabrizio Di Benedetto. Textbook of Robotic Liver Surgery. 2024; : 105 doi: 10.1007/978-3-031-76536-0_13
|
| 16 |
Roberto Iezzi, Andrea Contegiacomo, Alessandro Tanzilli, Alessandro Posa. Transarterial Chemoembolization (TACE). 2023; : 95 doi: 10.1007/978-3-031-36261-3_12
|
| 17 |
Chaohua Lv, Qingsong Wan, Chengxiang Shen, Hongsheng Wu, Bin Zhou, Weiwei Wang. Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expression. Molecular Medicine Reports 2021; 24(5) doi: 10.3892/mmr.2021.12420
|
| 18 |
Kyoko Oura, Asahiro Morishita, Tsutomu Masaki. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review. International Journal of Molecular Sciences 2020; 21(21): 8362 doi: 10.3390/ijms21218362
|
| 19 |
Paula M. Novelli, Philip D. Orons. The role of interventional radiology in the pre-liver transplant patient. Abdominal Radiology 2021; 46(1): 124 doi: 10.1007/s00261-020-02704-2
|
| 20 |
Nazli Pinar Karahan Şen, Özkan Alataş, Aytaç Gülcü, Özhan Özdoğan, Erkan Derebek, Gamze Çapa Kaya. The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer. Nuclear Medicine Communications 2022; doi: 10.1097/MNM.0000000000001572
|
| 21 |
Russell J. Stewart, Monika Sima, Jessica Karz, Joshua P. Jones. Material characterization of GPX®: A versatile in situ solidifying embolic platform technology. Frontiers in Bioengineering and Biotechnology 2023; 11 doi: 10.3389/fbioe.2023.1095148
|
| 22 |
Karolina Galmén, Jan G. Jakobsson, Jacob Freedman, Piotr Harbut. Post‐operative hypertension during early recovery following liver tumour ablation: A retrospective study. Acta Anaesthesiologica Scandinavica 2021; 65(9): 1248 doi: 10.1111/aas.13930
|
| 23 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|
| 24 |
Anil C. Anand, Subrat K. Acharya. New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy. Journal of Clinical and Experimental Hepatology 2021; 11(3): 284 doi: 10.1016/j.jceh.2021.04.003
|
| 25 |
Andrea Paladini, Marco Spinetta, Roberta Matheoud, Andrea D’Alessio, Miriana Sassone, Riccardo Di Fiore, Carolina Coda, Serena Carriero, Pierpaolo Biondetti, Domenico Laganà, Roberto Minici, Vittorio Semeraro, Gian Mauro Sacchetti, Gianpaolo Carrafiello, Giuseppe Guzzardi. Role of Flex-Dose Delivery Program in Patients Affected by HCC: Advantages in Management of Tare in Our Experience. Journal of Clinical Medicine 2024; 13(8): 2188 doi: 10.3390/jcm13082188
|
| 26 |
Yu-Jen Wu, Wen-Chi Wei, Guo-Fong Dai, Jui-Hsin Su, Yu-Hwei Tseng, Tsung-Chang Tsai. Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma. Marine Drugs 2020; 18(6): 314 doi: 10.3390/md18060314
|
| 27 |
Ahmed Nasser, Victoria Smith, Niamh Campbell, Michael Devin Rivers-Bowerman, Ashley Elispath Stueck, Andreu Francesc Costa, Riley Arseneau, Lauren Westhaver, Boris Luis Gala-Lopez. Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?. International Journal of Gastrointestinal Intervention 2023; 12(3): 145 doi: 10.18528/ijgii230020
|
| 28 |
Doina Pisla, Vaida Calin, Iosif Birlescu, Nadim Al Hajjar, Bogdan Gherman, Corina Radu, Nicolae Plitea. Risk Management for the Reliability of Robotic Assisted Treatment of Non-resectable Liver Tumors. Applied Sciences 2019; 10(1): 52 doi: 10.3390/app10010052
|
| 29 |
Joseph H. Yacoub, Christine C. Hsu, Thomas M. Fishbein, David Mauro, Andrew Moon, Aiwu R. He, Mustafa R. Bashir, Lauren M. B. Burke. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intention. Abdominal Radiology 2021; 46(8): 3528 doi: 10.1007/s00261-021-03069-w
|
| 30 |
Amir A. Borhani, Roberta Catania, Yuri S. Velichko, Stefanie Hectors, Bachir Taouli, Sara Lewis. Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response. Abdominal Radiology 2021; 46(8): 3674 doi: 10.1007/s00261-021-03085-w
|
| 31 |
Wenying Qiao, Shugui Sheng, Yiqi Xiong, Ming Han, Ronghua Jin, Caixia Hu. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1369988
|
| 32 |
Masaud Shah, Muhammad Hussain, Hyun Goo Woo. Structural insights into antibody-based immunotherapy for hepatocellular carcinoma. Genomics & Informatics 2025; 23(1) doi: 10.1186/s44342-024-00033-0
|
| 33 |
Pipit Burasakarn, Sermsak Hongjinda, Anuparp Thienhiran, Nichaphat Phancharoenkit, Pusit Fuengfoo. Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study. International Journal of Gastrointestinal Intervention 2023; 12(4): 169 doi: 10.18528/ijgii230025
|
| 34 |
Hidenori Mitani, Akira Naito, Keigo Chosa, Hisayuki Kodama, Masumi Sumida, Takashi Moriya, Kazuo Awai. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome. Minimally Invasive Therapy & Allied Technologies 2022; 31(6): 894 doi: 10.1080/13645706.2021.1995436
|
| 35 |
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World Journal of Hepatology 2020; 12(10): 738-753 doi: 10.4254/wjh.v12.i10.738
|
| 36 |
Yashwant Patidar, Gaurav Meena, Amar Mukund, Manoj K. Sharma, Shiv K. Sarin. Association of Serum ɣ-Glutamyl Transpeptidase Levels With Overall Survival in Intermediate and Advanced Hepatocellular Carcinoma Treated With Transarterial Chemoembolization. Journal of Clinical and Experimental Hepatology 2023; 13(6): 934 doi: 10.1016/j.jceh.2023.04.009
|
| 37 |
Qiao Zhang, Feng Xia, Hengyi Gao, Zhenheng Wu, Wenjing Cao, Qingfeng Xiang, Zhifeng Guan, Yang Su, Weiqiao Zhang, Weiqiang Chen, Ali Mo, Shuqun Li. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective Study. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.895426
|
| 38 |
Branislav Radjenović, Martin Sabo, Lukaš Šoltes, Marta Prnova, Pavel Čičak, Marija Radmilović-Radjenović. On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular Carcinoma. Cancers 2021; 13(22): 5784 doi: 10.3390/cancers13225784
|
| 39 |
Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA. Hepatic Oncology 2021; 8(3) doi: 10.2217/hep-2021-0001
|
| 40 |
Xiang’an Wu, Bao Jin, Xiao Liu, Yilei Mao, Xueshuai Wan, Shunda Du. Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis. Human Vaccines & Immunotherapeutics 2024; 20(1) doi: 10.1080/21645515.2024.2426869
|
| 41 |
Kuo-Liang Wei, Guan-Lun Gao, Yu-Ting Chou, Chih-Yi Lin, Shan-Chun Chen, Yi-Ling Chen, Hui Qin Choi, Chi-Chia Cheng, Jyan-Gwo Joseph Su. Sorafenib is an antagonist of the aryl hydrocarbon receptor. Toxicology 2022; 470: 153118 doi: 10.1016/j.tox.2022.153118
|
| 42 |
Souha H. Youssef, Raja Ganesan, Marzieh Amirmostofian, Sangseo Kim, Ruhi Polara, Franklin Afinjuomo, Yunmei Song, Bradley Chereda, Nimit Singhal, Nirmal Robinson, Sanjay Garg. Printing a cure: A tailored solution for localized drug delivery in liver cancer treatment. International Journal of Pharmaceutics 2024; 651: 123790 doi: 10.1016/j.ijpharm.2024.123790
|
| 43 |
Alessandro Posa, Andrea Contegiacomo, Francesca Romana Ponziani, Ernesto Punzi, Giulia Mazza, Annarita Scrofani, Maurizio Pompili, Shraga Nahum Goldberg, Luigi Natale, Antonio Gasbarrini, Evis Sala, Roberto Iezzi. Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends. International Journal of Molecular Sciences 2023; 24(8): 7344 doi: 10.3390/ijms24087344
|
| 44 |
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
|
| 45 |
Peter Konyn, Aijaz Ahmed, Donghee Kim. Current epidemiology in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(11): 1295 doi: 10.1080/17474124.2021.1991792
|
| 46 |
Paolo Magistri, Stefano Di Sandro, Fabrizio Di Benedetto. Hepatocellular Carcinoma. Updates in Surgery 2023; : 97 doi: 10.1007/978-3-031-09371-5_12
|
| 47 |
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
|
| 48 |
Lauren J. Delaney, Mohamed Tantawi, Corinne E. Wessner, Priscilla Machado, Flemming Forsberg, Andrej Lyshchik, Patrick O'Kane, Ji-Bin Liu, Jesse Civan, Allison Tan, Kevin Anton, Colette M. Shaw, John R. Eisenbrey. Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences. Ultrasound in Medicine & Biology 2021; 47(9): 2523 doi: 10.1016/j.ultrasmedbio.2021.05.006
|
| 49 |
S. Lewis, A. Barry, M.A. Hawkins. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size. Clinical Oncology 2022; 34(5): e195 doi: 10.1016/j.clon.2022.02.021
|
| 50 |
Neil Mehta. Hepatocellular Carcinoma—How to Determine Therapeutic Options. Hepatology Communications 2020; 4(3): 342 doi: 10.1002/hep4.1481
|
| 51 |
Ashif Ahamed, Mahmadul Hasan, Arijit Samanta, Syed Sahajada Mahafujul Alam, Zarnain Jamil, Safdar Ali, Mehboob Hoque. Prospective pharmacological potential of cryptotanshinone in cancer therapy. Pharmacological Research - Modern Chinese Medicine 2023; 9: 100308 doi: 10.1016/j.prmcm.2023.100308
|
| 52 |
Marija Radmilović-Radjenović, Nikola Bošković, Martin Sabo, Branislav Radjenović. An Analysis of Microwave Ablation Parameters for Treatment of Liver Tumors from the 3D-IRCADb-01 Database. Biomedicines 2022; 10(7): 1569 doi: 10.3390/biomedicines10071569
|
| 53 |
Min Meng, Wenhong Li, Xia Yang, Guanghui Huang, Zhigang Wei, Yang Ni, Xiaoying Han, Jiao Wang, Xin Ye. Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI). Journal of Cancer Research and Therapeutics 2020; 16(2): 327 doi: 10.4103/jcrt.JCRT_101_20
|
| 54 |
Anushree Udupi, Sachin Shetty, Jesil Mathew Aranjani, Rajesh Kumar, Sanjay Bharati. Anticancer therapeutic potential of multimodal targeting agent- “phosphorylated galactosylated chitosan coated magnetic nanoparticles” against N-nitrosodiethylamine-induced hepatocellular carcinoma. Drug Delivery and Translational Research 2025; 15(3): 1023 doi: 10.1007/s13346-024-01655-1
|
| 55 |
Ozgul Ekmekcioglu, Omer Naci Tabakci, Nihal Bozdag Kaplan, Aylin Hasanefendioglu Bayrak, Muharrem Battal. Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience. European Journal of Gastroenterology & Hepatology 2021; 33(6): 926 doi: 10.1097/MEG.0000000000002117
|
| 56 |
Ying-Le Tang, Yan Tao, Lin Zhu, Jia-Lin Shen, Hong Cheng. Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword. International Immunopharmacology 2023; 118: 110107 doi: 10.1016/j.intimp.2023.110107
|
| 57 |
Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj. Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(23): 16773 doi: 10.3390/ijms242316773
|
| 58 |
Cristina Micali, Ylenia Russotto, Grazia Caci, Manuela Ceccarelli, Andrea Marino, Benedetto Maurizio Celesia, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV. Infectious Disease Reports 2022; 14(1): 43 doi: 10.3390/idr14010006
|
| 59 |
Stephen Susman, Breanna Santoso, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(10): 2226 doi: 10.3390/biomedicines12102226
|
| 60 |
Anum Aslam, Richard Kinh Gian Do, Victoria Chernyak, Mishal Mendiratta-Lala. LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence. Current Hepatology Reports 2020; 19(4): 437 doi: 10.1007/s11901-020-00546-6
|
| 61 |
Sha Yang, Huapeng Lin, Jianning Song. Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02365-1
|
| 62 |
Yehua Shen, Chien-shan Cheng, Peng Wang, Xu Zhu, Guangyan Lei, Yong Fang, Hailiang Li, Weijun Fan, Hongming Pan, Zhe Tang, Kuansheng Ma, Xiaoguang Li, Zhengyu Lin, Yiping Zhuang, Xin Ye, Bo Zhai, Yue Han, Jinhua Huang, Huixiong Xu, Rongqin Zheng, Rufu Chen, Jie Yu, Dong Xu, Zhongmin Wang, Zhiqiang Meng. CSCO ablation expert workshop report. Journal of Cancer Research and Therapeutics 2020; 16(2): 350 doi: 10.4103/jcrt.JCRT_480_20
|
| 63 |
Bahareh Farasati Far, Ali Attaripour Isfahani, Elnaz Nasiriyan, Ali Pourmolaei, Golnaz Mahmoudvand, Arian Karimi Rouzbahani, Mohammed Namiq Amin, Mohammad Reza Naimi-Jamal. An Updated Review on Advances in Hydrogel-Based Nanoparticles for Liver Cancer Treatment. Livers 2023; 3(2): 161 doi: 10.3390/livers3020012
|
| 64 |
Congjian Shi, Hongqin Yang, Zhenghong Zhang. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00139
|
| 65 |
Mohamed Tantawi, Susan Shamimi-Noori, Colette M. Shaw, John R. Eisenbrey. State of the Art: Contrast Enhanced 4D Ultrasound to Monitor or Assess Locoregional Therapies. Digestive Disease Interventions 2022; 6(01): 003 doi: 10.1055/s-0041-1741520
|
| 66 |
Mina S Makary, Stuart Ramsell, Eric Miller, Eliza W Beal, Joshua D Dowell. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World Journal of Gastroenterology 2021; 27(43): 7462-7479 doi: 10.3748/wjg.v27.i43.7462
|
| 67 |
Satheesh Selvaraj, Ankush Chauhan, Ritesh Verma, Vishal Dutta, Garima Rana, Rohit Duglet, Rajasekaran Subbarayan, Khalid Mujasam Batoo. Role of degrading hydrogels in hepatocellular carcinoma drug delivery applications: A review. Journal of Drug Delivery Science and Technology 2024; 95: 105628 doi: 10.1016/j.jddst.2024.105628
|
| 68 |
Corina Radu, Petra Fisher, Delia Mitrea, Iosif Birlescu, Tiberiu Marita, Flaviu Vancea, Vlad Florian, Cristian Tefas, Radu Badea, Horia Ștefănescu, Sergiu Nedevschi, Doina Pisla, Nadim Al Hajjar. Integration of Real-Time Image Fusion in the Robotic-Assisted Treatment of Hepatocellular Carcinoma. Biology 2020; 9(11): 397 doi: 10.3390/biology9110397
|
| 69 |
Carmen Ali Zarad, Waleed Elagawy, Basma Badreldin Hasan, Sherief Abd-Elsalam, Waleed S. Abo Shanab. Value of CT and MR Imaging in Assessment of Loco-regional Ablated
Hepatocellular Carcinoma using LI-RADS Treatment Response Algorithm
(version 2018). Current Cancer Therapy Reviews 2023; 19(3): 260 doi: 10.2174/1573394719666230117111353
|
| 70 |
Wenchao Hu, Guohong Cao, Shengli Ye, Jianfeng Xu, Jing Chen, Guoliang Shao. Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE. Medicine 2023; 102(24): e34054 doi: 10.1097/MD.0000000000034054
|
| 71 |
Shan Jin, Shisheng Tan, Wen Peng, Ying Jiang, Chunshan Luo. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01966-w
|
| 72 |
Mina S. Makary, Jordan Bozer, Eric D. Miller, Dayssy A. Diaz, Ali Rikabi. Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience. Academic Radiology 2024; 31(5): 1828 doi: 10.1016/j.acra.2023.07.007
|
| 73 |
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
|
| 74 |
Joanna Jiang, Erin Bouquet, Yesung Kweon, Mohamed I. Elsaid, Dayssy A. Diaz, Lanla Conteh, Lindsay A. Sobotka. Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(10): 102485 doi: 10.1016/j.clinre.2024.102485
|
| 75 |
Xiao Ni Ma, Yoon Khei Ho, Jian Yi Gerald Goie, Cheng-Xu Ma, Zong-Bin Sun, Li-Qiong Yao, Xiao Liang Zhu, Jun Yung Woo, Heng-Phon Too, Xun Li. Evaluating the potential of off-the-shelf engineered mesenchymal stem cells for targeted Hepatocellular Carcinoma treatment: A multisite proof-of-concept study. Biomedicine & Pharmacotherapy 2024; 181: 117676 doi: 10.1016/j.biopha.2024.117676
|
| 76 |
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma. Cancers 2024; 16(13): 2430 doi: 10.3390/cancers16132430
|
| 77 |
Roberto Iezzi, Alessandro Posa, Alessandro Tanzilli, Francesca Carchesio, Maurizio Pompili, Riccardo Manfredi. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC. CardioVascular and Interventional Radiology 2020; 43(11): 1702 doi: 10.1007/s00270-020-02583-6
|
| 78 |
Yi Luo, Lei Song, Xinyu Wang, Yujie Huang, Yongqiang Liu, Qi Wang, Ming Hong, Zhongyu Yuan. Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01264
|
| 79 |
Jian Huang, Zhen-Guang Wang, Qi-Fei Tao, Yun Yang, Sheng-Xian Yuan, Fang-Ming Gu, Hui Liu, Ze-Ya Pan, Bei-Ge Jiang, Wan Yee Lau, Wei-Ping Zhou. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1198562
|
| 80 |
Minhan Jiang, Steven Fiering, Qi Shao. Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1153066
|